![Figure 1 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar Figure 1 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5b5fe1753c6637c3d8d05d3474c75480496dc8b7/7-Figure1-1.png)
Figure 1 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar
Get Psorted: Understanding Psoriasis - Find the PASI assessment process confusing? Check out this simple explanation about the Psoriasis Area and Severity Index (PASI) and how it works to assess the intensity
![Table 3 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar Table 3 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5b5fe1753c6637c3d8d05d3474c75480496dc8b7/8-Table3-1.png)
Table 3 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar
![POCKET.MD - Psoriasis Severity Calculator, PASI(Psoriasis Area Severity Index) is a measure of overall psoriasis severity and coverage, and BS... POCKET.MD - Psoriasis Severity Calculator, PASI(Psoriasis Area Severity Index) is a measure of overall psoriasis severity and coverage, and BS...](http://www.pocket.md/images/appImages/screenshots/1384596010.jpeg)
POCKET.MD - Psoriasis Severity Calculator, PASI(Psoriasis Area Severity Index) is a measure of overall psoriasis severity and coverage, and BS...
![Secukinumab efficacy in reducing the severity and the psychosocial impact of moderate‐to‐severe psoriasis as assessed by the Simplified Psoriasis Index: results from the IPSI‐PSO study - Richard - 2021 - Journal of Secukinumab efficacy in reducing the severity and the psychosocial impact of moderate‐to‐severe psoriasis as assessed by the Simplified Psoriasis Index: results from the IPSI‐PSO study - Richard - 2021 - Journal of](https://onlinelibrary.wiley.com/cms/asset/85d48eca-71ce-42ea-9c50-3f367fac9326/jdv16893-fig-0001-m.jpg)
Secukinumab efficacy in reducing the severity and the psychosocial impact of moderate‐to‐severe psoriasis as assessed by the Simplified Psoriasis Index: results from the IPSI‐PSO study - Richard - 2021 - Journal of
![Correlation between psoriasis area severity index score and metabolic syndrome in psoriatic patients in Menoufia University Mohaseb AI, El-Farargy SM, Yasien HA, Ghanayem NM - Menoufia Med J Correlation between psoriasis area severity index score and metabolic syndrome in psoriatic patients in Menoufia University Mohaseb AI, El-Farargy SM, Yasien HA, Ghanayem NM - Menoufia Med J](https://www.mmj.eg.net/articles/2021/34/3/images/MenoufiaMedJ_2021_34_3_896_328337_t6.jpg)
Correlation between psoriasis area severity index score and metabolic syndrome in psoriatic patients in Menoufia University Mohaseb AI, El-Farargy SM, Yasien HA, Ghanayem NM - Menoufia Med J
![Comparison of efficacy, safety, and cost-effectiveness of topical salicylic acid 6% versus clobetasol propionate 0.05% in the treatment of limited chronic plaque psoriasis Comparison of efficacy, safety, and cost-effectiveness of topical salicylic acid 6% versus clobetasol propionate 0.05% in the treatment of limited chronic plaque psoriasis](https://www.jhrr.org/articles/2018/5/2/images/JHealthResRev_2018_5_2_86_238863_f1.jpg)
Comparison of efficacy, safety, and cost-effectiveness of topical salicylic acid 6% versus clobetasol propionate 0.05% in the treatment of limited chronic plaque psoriasis
![Analysis of Body Regions and Components of PASI Scores During Adalimumab or Methotrexate Treatment for Patients With Moderate-to-Severe Psoriasis - JDDonline - Journal of Drugs in Dermatology Analysis of Body Regions and Components of PASI Scores During Adalimumab or Methotrexate Treatment for Patients With Moderate-to-Severe Psoriasis - JDDonline - Journal of Drugs in Dermatology](http://dl.jddonline.com/articleimages/article_2456/table1.png)